Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8443394rdf:typepubmed:Citationlld:pubmed
pubmed-article:8443394lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:8443394lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8443394lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:8443394lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:8443394lifeskim:mentionsumls-concept:C0063710lld:lifeskim
pubmed-article:8443394lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:8443394lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:8443394lifeskim:mentionsumls-concept:C1155002lld:lifeskim
pubmed-article:8443394lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:8443394pubmed:issue5lld:pubmed
pubmed-article:8443394pubmed:dateCreated1993-4-6lld:pubmed
pubmed-article:8443394pubmed:abstractTextInterleukin-1 (IL-1) profoundly affects a number of functions of endothelial cells (EC). It was previously shown that EC express the type I 80-Kd IL-1 receptor (IL-1 RI). In this study we define the expression and functional significance of the type II IL-1R (IL-1 RII) in EC. Human umbilical vein EC did not express appreciable levels of IL-1 RII mRNA as assessed by Northern analysis or reverse transcription and polymerase chain reaction. Exposure to various cytokines (including IL-4, which augments IL-1 RII in neutrophils) failed to induce IL-1 RII mRNA. The binding of radiolabeled IL-1 beta to EC was blocked by antitype I (M4) but not by antitype II (M22) monoclonal antibodies (MoAbs). MoAbs directed against the IL-1 RI (M1 and M4) inhibited the induction of IL-6 and adhesion molecules in EC by IL-1, whereas an anti-IL-1 RII (M22) was inactive. The human IL-1 receptor antagonist (IL-1ra) preferentially interacts with IL-1 RI versus IL-1 RII in the mouse. IL-1 ra inhibited the response of mouse endothelial cells to IL-1. We conclude that EC selectively express the IL-1 RI and that this is involved in the response of this cell type to IL-1.lld:pubmed
pubmed-article:8443394pubmed:languageenglld:pubmed
pubmed-article:8443394pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8443394pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8443394pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8443394pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8443394pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8443394pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8443394pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8443394pubmed:statusMEDLINElld:pubmed
pubmed-article:8443394pubmed:monthMarlld:pubmed
pubmed-article:8443394pubmed:issn0006-4971lld:pubmed
pubmed-article:8443394pubmed:authorpubmed-author:BernasconiSSlld:pubmed
pubmed-article:8443394pubmed:authorpubmed-author:MantovaniAAlld:pubmed
pubmed-article:8443394pubmed:authorpubmed-author:BoraschiDDlld:pubmed
pubmed-article:8443394pubmed:authorpubmed-author:SironiMMlld:pubmed
pubmed-article:8443394pubmed:authorpubmed-author:PollicinaFFlld:pubmed
pubmed-article:8443394pubmed:authorpubmed-author:ColottaFFlld:pubmed
pubmed-article:8443394pubmed:authorpubmed-author:BorrèAAlld:pubmed
pubmed-article:8443394pubmed:issnTypePrintlld:pubmed
pubmed-article:8443394pubmed:day1lld:pubmed
pubmed-article:8443394pubmed:volume81lld:pubmed
pubmed-article:8443394pubmed:ownerNLMlld:pubmed
pubmed-article:8443394pubmed:authorsCompleteYlld:pubmed
pubmed-article:8443394pubmed:pagination1347-51lld:pubmed
pubmed-article:8443394pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:meshHeadingpubmed-meshheading:8443394-...lld:pubmed
pubmed-article:8443394pubmed:year1993lld:pubmed
pubmed-article:8443394pubmed:articleTitleType II interleukin-1 receptor is not expressed in cultured endothelial cells and is not involved in endothelial cell activation.lld:pubmed
pubmed-article:8443394pubmed:affiliationCentro Daniela e Catullo Borgomainerio, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.lld:pubmed
pubmed-article:8443394pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8443394pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8443394lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8443394lld:pubmed